ArticleOncotarget2021

The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study.

Vandana M Sagar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.